Quality Improvement and Implementation Science for Mental and Physical Health in Women Veterans
(EMPOWER Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve healthcare services for women Veterans by testing two strategies to implement effective practices at VA facilities. One strategy, REP, adapts proven methods like buprenorphine to local needs. The other, EBQI, provides more intensive support and training in quality improvement. The goal is to ensure women Veterans receive and are more likely to use the services they need. This trial does not recruit individual patients but collaborates with VA facilities that have leadership support to participate. As an unphased trial, it offers a unique opportunity to enhance healthcare services for women Veterans.
Will I have to stop taking my current medications?
The trial does not involve individual patients, so there is no requirement for participants to stop taking their current medications.
What prior data suggests that these implementation strategies are safe for women Veterans?
Research shows that both strategies being tested, EBQI and REP, have been used in past studies with women Veterans. EBQI involves training and support to enhance care quality. Studies have evaluated its effectiveness in health systems for women Veterans, and no specific safety concerns have emerged.
REP is a simpler method that adapts proven practices to local settings. Research on REP has focused on making health services more accessible and personalized. Previous studies have also not identified any specific safety issues with this approach.
Both strategies are not typical medical treatments but aim to improve healthcare delivery. Since they do not involve medication or direct medical procedures, they are generally well-tolerated and do not carry the same safety risks as new drugs or surgeries.12345Why are researchers excited about this trial?
Researchers are excited about the trial for implementing quality improvement strategies in mental and physical health care for women veterans because it explores innovative methods to enhance healthcare delivery. Unlike traditional treatments that focus solely on patient symptoms, the trial uses Evidence-Based Quality Improvement (EBQI) and Replicating Effective Practices (REP) to improve how care is provided. EBQI involves external facilitation and formal training, offering a high-intensity approach to ensure healthcare providers can continuously improve their services. REP, on the other hand, uses a structured framework to tailor practices locally, making it a flexible and adaptable strategy. These approaches aim to boost the overall quality of care and patient outcomes, offering a fresh perspective on healthcare improvement.
What evidence suggests that this trial's treatments could be effective for women Veterans?
This trial will compare two strategies: Evidence-Based Quality Improvement (EBQI) and Replicating Effective Practices (REP), to enhance healthcare for women Veterans. Research has shown that EBQI helps implement new care models to address gaps in primary care for women Veterans. This approach has improved the delivery of care sensitive to women's needs, leading to better quality and patient experiences. REP offers a clear method for adapting successful practices to local settings. Studies suggest that these methods can improve access to and the quality of healthcare services for women Veterans. Both strategies aim to reduce health disparities and enhance the overall well-being of women Veterans.12678
Who Is on the Research Team?
Alison B Hamilton, PhD MPH
Principal Investigator
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
Are You a Good Fit for This Trial?
This trial is for VA facilities that serve women veterans. It's not for individual patients. Facilities must have leadership support to participate and are prepared to implement evidence-based practices aimed at improving health outcomes in areas like diabetes, obesity, depression, and cardiovascular disease.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Randomization of VA sites to REP or EBQI strategies to implement evidence-based practices for preventive services
Evaluation
Mixed methods implementation evaluation to compare effectiveness of REP and EBQI strategies
Follow-up
Participants are monitored for engagement and outcomes in virtual preventive services
What Are the Treatments Tested in This Trial?
Interventions
- DPP
- EBQI
- REP
- ROSE
- TLC
DPP is already approved in United States, European Union, Canada for the following indications:
- Prediabetes prevention
- Type 2 diabetes prevention
- Prediabetes prevention
- Type 2 diabetes prevention
- Prediabetes prevention
- Type 2 diabetes prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor